Skip to main content
Top
Published in:

17-07-2024 | Breast Cancer | ASO Author Reflections

ASO Author Reflections: Trajectory of Subsequent Breast Cancer After Breast Atypia Diagnosis Suggests Need for Vigilant Follow-up

Authors: Jessica N. Limberg, MD, E. Shelley Hwang, MD, MPH

Published in: Annals of Surgical Oncology | Issue 11/2024

Login to get access

Excerpt

Proliferative atypical lesions of the breast are common benign entities that have been consistently shown to independently increase a woman’s risk of developing future breast cancer. Studies report a 20-year cumulative risk of developing in situ or invasive disease of at least 20%.13 Despite this well-established inherent risk, little is known about the timing of breast cancer development or clinicopathologic features that may influence its trajectory. …
Literature
1.
go back to reference Morrow M, Schnitt SJ, Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol. 2015;12(4):227–38.CrossRefPubMed Morrow M, Schnitt SJ, Norton L. Current management of lesions associated with an increased risk of breast cancer. Nat Rev Clin Oncol. 2015;12(4):227–38.CrossRefPubMed
2.
go back to reference Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study Cancer. 1985;55(11):2698–708.PubMed Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study Cancer. 1985;55(11):2698–708.PubMed
3.
go back to reference Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146–51.CrossRefPubMed Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146–51.CrossRefPubMed
5.
go back to reference Lazzeroni M, Puntoni M, Guerrieri-Gonzaga A, Serrano D, Boni L, Buttiron Webber T, et al. Randomized placebo controlled trial of low-dose tamoxifen to prevent recurrence in breast noninvasive neoplasia: a 10-year follow-up of TAM-01 study. J Clin Oncol. 2023;41(17):3116–21.CrossRefPubMed Lazzeroni M, Puntoni M, Guerrieri-Gonzaga A, Serrano D, Boni L, Buttiron Webber T, et al. Randomized placebo controlled trial of low-dose tamoxifen to prevent recurrence in breast noninvasive neoplasia: a 10-year follow-up of TAM-01 study. J Clin Oncol. 2023;41(17):3116–21.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Trajectory of Subsequent Breast Cancer After Breast Atypia Diagnosis Suggests Need for Vigilant Follow-up
Authors
Jessica N. Limberg, MD
E. Shelley Hwang, MD, MPH
Publication date
17-07-2024
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 11/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-15869-7
SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now
Video